|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/496 | |
| A61P 3/06 | |||
| A61P 3/10 | |||
| C07D 417/14 |
| (11) | Number of the document | 1882474 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06732351.9 |
| Date of filing the European patent application | 2006-04-26 | |
| (97) | Date of publication of the European application | 2008-01-30 |
| (45) | Date of publication and mention of the grant of the patent | 2010-11-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2006/308695 |
| Date | 2006-04-26 |
| (87) | Number | WO 2006/118127 |
| Date | 2006-11-09 |
| (30) | Number | Date | Country code |
| 2005127523 | 2005-04-26 | JP |
| (72) |
ABE, Yuji, JP
KUSUNOKI, Aki, JP
HAYASHI, Yoshiharu, JP
AKAHOSHI, Fumihiko, JP
|
| (73) |
Mitsubishi Tanabe Pharma Corporation,
2-6-18, Kitahama Chuo-ku Osaka-shi, Osaka 541-8505,
JP
|
| (54) | PROPHYLACTIC/THERAPEUTIC AGENT FOR ABNORMALITIES OF LIPID METABOLISM |
| PROPHYLACTIC/THERAPEUTIC AGENT FOR ABNORMALITIES OF LIPID METABOLISM |